At this time, patents prevent a generic Ulesfia (benzyl alcohol lotion) from being manufactured. The earliest predictable date that a generic version of the drug could become available is August 2017, when the first patent expires. However, lawsuits or other patents for specific uses of Ulesfia may delay the manufacturing of a generic version of the drug.
Ulesfia® (benzyl alcohol lotion) is a prescription head lice medication. It can be used in children as young as six months of age. It comes as a lotion and is usually applied two times, with seven days in between applications. Each application lasts 10 minutes.
Ulesfia is manufactured by Contract Pharmaceuticals Limited for Shionogi Pharma, Inc. In the United States, Ulesfia is protected by patents and is not available in generic form at this time.
The first patent for Ulesfia expires in August 2017. This is the earliest predictable date that a generic version could become available.
However, there are other circumstances that could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for specific Ulesfia uses. Once the drug goes off-patent, there may be several companies that manufacture a generic Ulesfia drug.
No -- benzyl alcohol is the active ingredient in Ulesfia, but it is not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off-patent, and another company besides the original manufacturer must make the product.